R-AD26-S (RECOMBINANT ADENOVIRUS TYPE 26 CARRYING THE GENE FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE GLYCOPROTEIN)
UNII C3JH443FGL

Substance Identification & Data

This profile provides standardized clinical and technical data for R-ad26-s (recombinant Adenovirus Type 26 Carrying The Gene For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-cov-2) Spike Glycoprotein), uniquely identified by the FDA Unique Ingredient Identifier (UNII) C3JH443FGL.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

C3JH443FGL

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

R-AD26-S (RECOMBINANT ADENOVIRUS TYPE 26 CARRYING THE GENE FOR SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE GLYCOPROTEIN)

Official standardized name for this substance within the FDA UNII nomenclature system.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for R-ad26-s (recombinant Adenovirus Type 26 Carrying The Gene For Severe Acute Respiratory Syndrome Coronavirus 2 (sars-cov-2) Spike Glycoprotein). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.